XML 172 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
Additional Paid-in Capital
CNY (¥)
 [1]
Statutory Reserve
CNY (¥)
Accumulated deficit
CNY (¥)
Accumulated Other Comprehensive income
CNY (¥)
Shareholders' Equity
CNY (¥)
Non-controlling Interest
CNY (¥)
Common stock
Class A ordinary shares
CNY (¥)
shares
Common stock
Class B ordinary shares
CNY (¥)
shares
CNY (¥)
shares
USD ($)
shares
Opening Balance at Jun. 30, 2020 ¥ 287,077,740 ¥ 4,148,929 ¥ (184,027,586) ¥ 2,825,731 ¥ 110,029,762 ¥ 10,614,526 ¥ 4,948 [1]   ¥ 120,644,288 $ 16,637,609
Opening Balance (in shares) at Jun. 30, 2020 [1]             454,883      
Capital contribution in non-controlling interests           50,000     50,000 6,895
Step acquisition of FGS           34,790,000     34,790,000 4,797,760
Capital contribution receivable due from non-controlling Interest           (50,000,000)     (50,000,000) (6,895,315)
Stock issuance 81,087,271       81,091,141   ¥ 3,870 [1]   81,091,141 11,182,980
Stock issuance (in shares) [1]             334,117      
Stock issuance for warrants exercised 21,128,345       21,130,035   ¥ 1,690 [1]   21,130,035 2,913,965
Stock issuance for warrants exercised (in shares) [1]             143,951      
Proceeds from Pre-founded warrants 30,275,713       30,276,569   ¥ 856 [1]   30,276,569 4,175,330
Proceeds from Pre-founded warrants (in shares) [1]             73,889      
Issuance of common share in exchange of shares of Starry, net of issuance costs 27,675,248       27,675,450   ¥ 202 [1]   27,675,450 3,816,619
Issuance of common share in exchange of shares of Starry, net of issuance costs (in shares) [1]             17,575      
Restricted shares issued for management 6,139,915       6,140,037   ¥ 122 [1]   6,140,037 846,750
Restricted shares issued for management (in shares) [1]             10,481      
Stock issuance for convertible notes redemption 42,429,692       42,435,669   ¥ 5,977 [1]   42,435,669 5,852,146
Stock issuance for convertible notes redemption (in shares) [1]             512,519      
Net income (loss) for the period     (22,832,734)   (22,832,734) (3,034,094)     (25,866,828) (3,567,199)
Foreign currency translation adjustment       (850,895) (850,895)       (850,895) (117,344)
Ending Balance at Jun. 30, 2021 495,813,924 4,148,929 (206,860,320) 1,974,836 295,095,034 (7,579,568) ¥ 17,665 [1]   287,515,466 39,650,196
Ending Balance (in shares) at Jun. 30, 2021 [1]             1,547,415      
Capital contribution in non-controlling interests           1,130,000     1,130,000 155,834
Restricted shares issued for services 8,934,933       8,935,919   ¥ 986 [1]   8,935,919 1,232,320
Restricted shares issued for services (in shares) [1]             86,111      
Stock issuance for Pre-founded warrants 92,392       93,321   ¥ 929 [1]   93,321 12,870
Stock issuance for Pre-founded warrants (in shares) [1]             81,667      
Cancellation of ordinary shares issued to Starry Lab (27,675,248)       (27,675,450)   ¥ (202) [1]   (27,675,450) (3,816,619)
Cancellation of ordinary shares issued to Starry Lab (in shares) [1]             (17,575)      
Restricted shares issued for management 39,260,798       39,263,485   ¥ 83 [1] ¥ 2,604 [1] 39,263,485 5,414,682
Restricted shares issued for management (in shares)             7,148 [1] 4,100,000 [2]    
Net income (loss) for the period     95,586,795   95,586,795 (1,297,400)     94,289,395 13,003,100
Foreign currency translation adjustment       9,332,625 9,332,625       9,332,625 1,287,028
Ending Balance at Jun. 30, 2022 516,426,799 4,148,929 (111,273,525) 11,307,461 420,631,729 (7,746,968) ¥ 19,461 [1] ¥ 2,604 [1] 412,884,761 56,939,411
Ending Balance (in shares) at Jun. 30, 2022             1,704,766 [1] 4,100,000 [2]    
Restricted shares issued for services 5,805,150       5,805,840   ¥ 690 [1]   5,805,840 800,662
Restricted shares issued for services (in shares) [1]             55,556      
Stock issuance 28,168,902       28,174,993   ¥ 6,091 [1]   28,174,993 3,885,509
Stock issuance (in shares) [1]             490,417      
Proceeds from Pre-founded warrants 3,750,282       3,750,282       3,750,282 517,188
Restricted shares issued for management 26,188,928       26,191,707   ¥ 690 [1] ¥ 2,089 [1] ¥ 26,191,707 $ 3,612,002
Restricted shares issued for management (in shares)             55,556 [1] 3,000,000 [2]    
Stock issuance for convertible notes redemption (in shares)                 9,225,338 9,225,338
Net income (loss) for the period     (59,167,301)   (59,167,301) (2,309,091)     ¥ (61,476,392) $ (8,477,982)
Foreign currency translation adjustment       23,819,712 23,819,712       23,819,712 3,284,889
Ending Balance at Jun. 30, 2023 ¥ 580,340,061 ¥ 4,148,929 ¥ (170,440,826) ¥ 35,127,173 ¥ 449,206,962 ¥ (10,056,059) ¥ 26,932 [1] ¥ 4,693 [1] ¥ 439,150,903 $ 60,561,679
Ending Balance (in shares) at Jun. 30, 2023             2,306,295 [1] 7,100,000 [2]    
[1] Retrospectively restated for the 1-for-18 reverse stock split on May 1, 2024 and change in capital structure on March 29, 2024.
[2] Retrospectively restated for effect of changing in class of shares on April 5, 2021.